Using the national cancer database for outcomes research a review

JAMA Oncology

Volumn 3, Issue 12, 2017, Pages 1722-1728

  Boffa, Daniel J ^a   Rosen, Joshua E ^e   Mallin, Katherine ^b   Loomis, Ashley ^b   Gay, Greer ^b   Palis, Bryan ^b   Thoburn, Kathleen ^b   Gress, Donna ^c   McKellar, Daniel P ^b   Shulman, Lawrence N ^b,d   Facktor, Matthew A ^b   Winchester, David P ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMERICAN COLLEGE OF SURGEONS   (United States)

^c American Joint Committee on Cancer   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e American College of Surgeons ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER REGISTRY; CANCER SURGERY; COLLEGE; HUMAN; JOINT; NON PROFIT ORGANIZATION; OUTCOMES RESEARCH; SURGEON; TOTAL QUALITY MANAGEMENT; UNITED STATES; FACTUAL DATABASE; HEALTH CARE QUALITY; MEDICAL SOCIETY; NEOPLASM; OUTCOME ASSESSMENT;

AMERICAN CANCER SOCIETY; DATABASES, FACTUAL; HUMANS; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); SEER PROGRAM; SOCIETIES, MEDICAL; STANDARD OF CARE; UNITED STATES;

EID: 85056247428     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2016.6905     Document Type: Article

References (37)

1. National Cancer Institute. SEER data 1973-2013. https://seer.cancer.gov/data/. Accessed October 13, 2016.
2. American College of Surgeons. National Cancer Database. https://www.facs.org/quality-programs/cancer/ncdb. Accessed October 14, 2016.
3. Blanchard P, Garden AS. Looking beyond the numbers: highlighting the challenges of population-based studies in cancer research. J Clin Oncol. 2016;34(19):2317-2318.
4. National Cancer Institute. SEER-Medicare publications by journal & year. https://healthcaredelivery.cancer.gov/seermedicare /overview/pubs_jour_year.php. Updated March 2, 2015. Accessed October 14, 2016.
5. Robinson CG, Patel AP, Bradley JD, et al. Postoperative radiotherapy for pathologic N2 non–small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base. J Clin Oncol. 2015;33(8):870-876.
6. Boland GM, Chang GJ, Haynes AB, et al. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer. Cancer. 2013;119(8):1593-1601.
7. American Hospital Association. Fast facts on US hospitals. http://www.aha.org/research/rc/stat-studies/fast-facts.shtml. Updated January 2017. Accessed January 21, 2017.
8. Bilimoria KY, Bentrem DJ, Stewart AK, Winchester DP, Ko CY. Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. J Clin Oncol. 2009;27(25):4177-4181.
9. Mohanty S, Bilimoria KY. Comparing national cancer registries: the National Cancer Data Base (NCDB) and the Surveillance, Epidemiology, and End Results (SEER) program. J Surg Oncol. 2014; 109(7):629-630.
10. Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15(3):683-690.
11. Commission on Cancer. Facility Oncology Registry Data Standards (FORDS): revised for 2016. https://www.facs.org/quality-programs/cancer/ncdb/registrymanuals/cocmanuals/fordsmanual. Published January 1, 2016. Accessed July 11, 2016.
12. Speicher PJ, Englum BR, Ganapathi AM, et al. Traveling to a high-volume center is associated with improved survival for patients with esophageal cancer [published online March 15, 2016]. Ann Surg. doi:10.1097/SLA.0000000000001702
13. American College of Surgeons. PUF data dictionary terms. http://ncdbpuf.facs.org/node/259. Accessed August 9, 2013.
14. National Cancer Institute. Required SEER site-specific factors for collaborative stage. https://seer.cancer.gov/tools/ssf/. Accessed July 11, 2016.
15. Hancock J, Rosen J, Moreno A, Kim AW, Detterbeck FC, Boffa DJ. Management of clinical stage IIIA primary lung cancers in the National Cancer Database. Ann Thorac Surg. 2014;98(2): 424-432.
16. Farjah F, Flum DR, Ramsey SD, Heagerty PJ, Symons RG, Wood DE. Multi-modality mediastinal staging for lung cancer among Medicare beneficiaries. J Thorac Oncol. 2009;4(3):355-363.
17. Rosen JE, Salazar MC, Wang Z, et al. Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer. J Thorac Cardiovasc Surg. 2016;152(1):44-54.e9.
18. Rosen JE, Keshava HB, Yao X, Kim AW, Detterbeck FC, Boffa DJ. The natural history of operable non-small cell lung cancer in the National Cancer Database. Ann Thorac Surg. 2016;101(5): 1850-1855.
19. Hanna N, Sun M, Meyer CP, et al. Survival analyses of patients with metastatic renal cancer treated with targeted therapy with or without cytoreductive nephrectomy: a National Cancer Data Base study. J Clin Oncol. 2016;34(27):3267-3275.
20. Sun Z, Adam MA, Kim J, et al. Determining the optimal timing for initiation of adjuvant chemotherapy after resection for stage II and III colon cancer. Dis Colon Rectum. 2016;59(2):87-93.
21. Salazar MC, Rosen JE, Wang Z, et al. Association of delayed adjuvant chemotherapy with survival after lung cancer surgery [published online January 5, 2017]. JAMA Oncol. 2017. doi:10.1001/jamaoncol .2016.5829
22. Stitzenberg KB, Chang Y, Smith AB, Nielsen ME. Exploring the burden of inpatient readmissions after major cancer surgery. J Clin Oncol. 2015;33(5): 455-464.
23. Freeman RK, Dilts JR, Ascioti AJ, Dake M, Mahidhara RS. A comparison of length of stay, readmission rate, and facility reimbursement after lobectomy of the lung. Ann Thorac Surg. 2013;96 (5):1740-1745.
24. Stitzenberg KB, Chang Y, Smith AB, Meyers MO, Nielsen ME. Impact of location of readmission on outcomes after major cancer surgery. Ann Surg Oncol. 2017;24(2):319-329.
25. Commission on Cancer, American College of Surgeons. Cancer program standards (2016 edition). https://www.facs.org/quality
26. %20programs/cancer/coc/standards. Published January 1, 2016. Accessed July 6, 2016.
27. In H, Bilimoria KY, Stewart AK, et al. Cancer recurrence: an important but missing variable in national cancer registries. Ann Surg Oncol. 2014;21 (5):1520-1529.
28. Commission on Cancer. A precautionary tale of an edit: date of first course of treatment and treatment status. http://newsmanager.commpartners.com/acscoc/issues/2011-08-31/13 .html. Published August 31, 2011. Accessed August 8, 2013.
29. Winchester DP, Stewart AK, Bura C, Jones RS. The National Cancer Data Base: a clinical surveillance and quality improvement tool. J Surg Oncol. 2004;85(1):1-3.
30. Winchester DP, Stewart AK, Phillips JL, Ward EE. The National Cancer Data Base: past, present, and future. Ann Surg Oncol. 2010;17(1):4-7.
31. National Cancer Institute. Overview of the SEER Program. https://seer.cancer.gov/about/overview.html. Accessed July 6, 2016.
32. Adamo M, Dickie L, Ruhl J. SEER Program Coding and Staging Manual 2016. Bethesda, MD: National Cancer Institute; January 2016.
33. Raval MV, Bilimoria KY, Stewart AK, Bentrem DJ, Ko CY. Using the NCDB for cancer care improvement: an introduction to available quality assessment tools. J Surg Oncol. 2009;99(8):488-490.
34. Lerro CC, Robbins AS, Phillips JL, Stewart AK. Comparison of cases captured in the National Cancer Data Base with those in population-based central cancer registries. Ann Surg Oncol. 2013;20 (6):1759-1765.
35. Grimmer L, Liederbach E, Velasco J, Pesce C, Wang C-H, Yao K. Variation in contralateral prophylactic mastectomy rates according to racial groups in young women with breast cancer, 1998 to 2011: a report from the National Cancer Data Base. J Am Coll Surg. 2015;221(1):187-196.
36. Bristow RE, Powell MA, Al-Hammadi N, et al. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status. J Natl Cancer Inst. 2013;105(11):823-832.
37. Bleicher RJ, Ruth K, Sigurdson ER, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2(3):330-339.